Nuclear Medicine Therapy Shows Long-Term Effectiveness for Malignant Neuroendocrine Tumors (VIDEO)

Society of Nuclear Medicine and Molecular Imaging

Caption

Dr. Irene Virgolini discusses a 12-year study of patients who received peptide receptor radionuclide therapy for malignant neuroendocrine tumors shows its long-term effectiveness, which also allows patients to maintain a high quality of life.

Credit

Dr. Irene Virgolini

Usage Restrictions

Please provide appropriate attribution.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.